| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $860.5M | +7.9% | -0.5% |
| Cost of Revenue | $481.1M | +9.5% | +8.0% |
| Gross Profit | $379.4M | +6.0% | -9.4% |
| R&D Expense | $98.3M | -1.9% | +0.2% |
| SG&A Expense | $242.5M | +4.8% | +5.5% |
| Operating Income | -$51.8M | -535.3% | -176.1% |
| Pre-tax Income | -$71.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $293.1M | +218.6% | +97.9% |
| Accounts Receivable | $550.9M | +5.4% | +2.3% |
| Inventory | $1.20B | -1.8% | -2.0% |
| Current Assets | $2.35B | +8.7% | +7.3% |
| Total Assets | $6.43B | +1.5% | +5.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$95.7M | — | — |
| Capital Expenditures | $68.2M | — | — |
| Investing Cash Flow | -$141.0M | — | — |
| Financing Cash Flow | $302.7M | — | — |
| Free Cash Flow | -$163.9M | — | — |
| — |
| -229.8% |
| Income Tax | -$14.1M | -354.8% | -195.3% |
| Net Income | -$59.6M | -884.2% | -245.7% |
| EPS (Basic) | -$0.41 | -920.0% | -251.9% |
| EPS (Diluted) | -$0.41 | -920.0% | -251.9% |
| $1.27B |
| -5.9% |
| -4.1% |
| Long-term Debt | $2.01B | -17.5% | -12.6% |
| Stockholders' Equity | $2.43B | +33.7% | +34.6% |